Page 24 - Read Online

Page 18 of 20 Manrique et al. Microbiome Res Rep 2024;3:23 https://dx.doi.org/10.20517/mrr.2023.80

94. EFSA Panel on Biological Hazards (BIOHAZ); Koutsoumanis K, Allende A, Alvarez-Ordóñez A, et al. Update of the list of
qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA
18: suitability of taxonomic units notified to EFSA until March 2023. EFSA J 2023;21:e08092. DOI
95. Piqué N, Berlanga M, Miñana-Galbis D. Health benefits of heat-killed (Tyndallized) probiotics: an overview. Int J Mol Sci
2019;20:2534. DOI PubMed PMC
96. Dronkers TMG, Ouwehand AC, Rijkers GT. Global analysis of clinical trials with probiotics. Heliyon 2020;6:e04467. DOI PubMed
PMC
97. Swanson KS, Gibson GR, Hutkins R, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus
statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 2020;17:687-701. DOI PubMed PMC
98. Gomez Quintero DF, Kok CR, Hutkins R. The future of synbiotics: rational formulation and design. Front Microbiol
2022;13:919725. DOI PubMed PMC
99. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics:
proposal of paraprobiotic concept). Genes Nutr 2011;6:261-74. DOI PubMed PMC
100. Duarte M, Oliveira AL, Oliveira C, Pintado M, Amaro A, Madureira AR. Current postbiotics in the cosmetic market - an update and
development opportunities. Appl Microbiol Biotechnol 2022;106:5879-91. DOI
101. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli-derived factors. J Clin
Gastroenterol 2014;48 Suppl 1:S18-22. DOI PubMed
102. Liang B, Xing D. The current and future perspectives of postbiotics. Probiotics Antimicrob Proteins 2023;15:1626-43. DOI PubMed
PMC
103. Li M, Mao J, Diaz I, et al. Multi-omic approach to decipher the impact of skincare products with pre/postbiotics on skin microbiome
and metabolome. Front Med 2023;10:1165980. DOI PubMed PMC
104. Rafique N, Jan SY, Dar AH, et al. Promising bioactivities of postbiotics: a comprehensive review. J Agric Food Res 2023;14:100708.
DOI
105. Thorakkattu P, Khanashyam AC, Shah K, et al. Postbiotics: current trends in food and pharmaceutical industry. Foods 2022;11:3094.
DOI PubMed PMC
106. Satokari R. Modulation of gut microbiota for health by current and next-generation probiotics. Nutrients 2019;11:1921. DOI
PubMed PMC
107. López-Moreno A, Acuña I, Torres-Sánchez A, et al. Next generation probiotics for neutralizing obesogenic effects: taxa culturing
searching strategies. Nutrients 2021;13:1617. DOI PubMed PMC
108. Cani PD, de Vos WM. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol 2017;8:1765.
DOI PubMed PMC
109. Depommier C, Van Hul M, Everard A, Delzenne NM, De Vos WM, Cani PD. Pasteurized Akkermansia muciniphila increases whole-
body energy expenditure and fecal energy excretion in diet-induced obese mice. Gut Microbes 2020;11:1231-45. DOI PubMed
PMC
110. Abot A, Brochot A, Pomié N, et al. Pasteurized Akkermansia muciniphila improves glucose metabolism is linked with increased
hypothalamic nitric oxide release. Heliyon 2023;9:e18196. DOI PubMed PMC
111. Stavropoulou E, Bezirtzoglou E. Probiotics in medicine: a long debate. Front Immunol 2020;11:2192. DOI PubMed PMC
112. da Silva JTS, Nagata CLP. Efficacy of prebiotics in promoting a healthy gut microbiota in adults and elderly persons in the
community. Nutrire 2021;46:18. DOI
113. Wang S, Xiao Y, Tian F, et al. Rational use of prebiotics for gut microbiota alterations: specific bacterial phylotypes and related
mechanisms. J Funct Foods 2020;66:103838. DOI
114. Martinson JNV, Walk ST. Escherichia coli residency in the gut of healthy human adults. EcoSal Plus 2020;9:10.1128/ecosalplus.esp-
0003. DOI PubMed PMC
115. Paquet JC, Claus SP, Cordaillat-Simmons M, et al. Entering first-in-human clinical study with a single-strain live biotherapeutic
product: input and feedback gained from the EMA and the FDA. Front Med 2021;8:716266. DOI PubMed PMC
116. Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information. 2016. Available from:
https://www.fda.gov/files/vaccines,%20blood%20&20biologics/published/Early-Clinical-Trials-With-Live-Biotherapeutic-Products--
Chemistry--Manufacturing--and-Control-Information--Guidance-for-Industry.pdf. [Last accessed on 15 Mar 2024].
117. Cordaillat-Simmons M, Rouanet A, Pot B. Live biotherapeutic products: the importance of a defined regulatory framework. Exp Mol
Med 2020;52:1397-406. DOI PubMed PMC
118. Rouanet A, Bolca S, Bru A, et al. Live biotherapeutic products, a road map for safety assessment. Front Med 2020;7:237. DOI
PubMed PMC
119. European Directorate for the Quality of Medicines & HealthCare (EDQM). Live Biotherapeutic Products (LBPs): European
Pharmacopoeia Commission sets unprecedented quality requirements. Available from: https://www.edqm.eu/en/w/live-
biotherapeutic-products-lbps-european-pharmacopoeia-commission-sets-unprecedented-quality-requirements. [Last accessed on 15
Mar 2024].
120. de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022;71:1020-32. DOI PubMed
PMC
121. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell
2012;148:1258-70. DOI PubMed PMC
122. Yip AYG, King OG, Omelchenko O, et al. Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by